Curium Pharma Overview

  • Status
  • Private

  • Employees
  • 3,800

Employees

  • Latest Deal Type
  • Debt - Acquisition
  • (Upcoming)

  • Financing Rounds
  • 20

  • Investments
  • 11

Curium Pharma General Information

Description

Manufacturer of radiopharmaceutical products intended to enhance the lives of people with cancer. The company specializes in the production and supply of radioactive tracers used in nuclear medicine, enabling doctors to accurately diagnose and treat cancer with effective treatment and proven patient outcomes.

Contact Information

Website
www.curiumpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 2 Seaport Lane
  • 2nd floor
  • Boston, MA 02210
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 2 Seaport Lane
  • 2nd floor
  • Boston, MA 02210
  • United States

Curium Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curium Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Curium Pharma‘s full profile, request access.

Request a free trial

Curium Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of radiopharmaceutical products intended to enhance the lives of people with cancer. The company specialize
Drug Discovery
Boston, MA
3,800 As of 2026

Waltham, MA
 

Columbus, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curium Pharma Competitors (34)

One of Curium Pharma’s 34 competitors is Ardelyx, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ardelyx Formerly VC-backed Waltham, MA
Navidea Biopharmaceuticals Corporate Backed or Acquired Columbus, OH
Mariana Oncology Formerly VC-backed Watertown, MA
ExCellThera Accelerator/Incubator Backed Montreal, Canada
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 34 competitors. Get the full list »

Curium Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curium Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Curium Pharma‘s full profile, request access.

Request a free trial

Curium Pharma Investments (11)

Curium Pharma’s most recent deal was a Buyout/LBO with ABSCINT. The deal was made on 10-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ABSCINT 10-Aug-2026 Buyout/LBO Diagnostic Equipment
Lantheus Holdings 03-Aug-2026 Buyout/LBO Other Devices and Supplies
Nucleis Radiopharmaceuticals 10-Apr-2025 Buyout/LBO Pharmaceuticals
Eczacıbaşı-Monrol 05-Apr-2024 Buyout/LBO Pharmaceuticals
IASON 31-May-2021 Buyout/LBO Pharmaceuticals
You’re viewing 5 of 11 investments. Get the full list »

Curium Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
ABSCINT Liège, Belgium 2020

Curium Pharma FAQs

  • Where is Curium Pharma headquartered?

    Curium Pharma is headquartered in Boston, MA.

  • What is the size of Curium Pharma?

    Curium Pharma has 3,800 total employees.

  • What industry is Curium Pharma in?

    Curium Pharma’s primary industry is Drug Discovery.

  • Is Curium Pharma a private or public company?

    Curium Pharma is a Private company.

  • What is Curium Pharma’s current revenue?

    The current revenue for Curium Pharma is .

  • How much funding has Curium Pharma raised over time?

    Curium Pharma has raised $4.44B.

  • Who are Curium Pharma’s investors?

    Ardian France, Lunate, TPG, and CapVest Partners have invested in Curium Pharma.

  • Who are Curium Pharma’s competitors?

    Ardelyx, Navidea Biopharmaceuticals, Mariana Oncology, ExCellThera, and Inovio Pharmaceuticals are some of the 34 competitors of Curium Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process